O ur understanding of ventricular tachycardia (VT) substrate and mapping has evolved considerably over the past 3 decades. Nonetheless, the outcomes of catheter ablation of scar-mediated VT continue to remain far from perfect. 1 There is no doubt that new advances in VT mapping may help improve the outcomes of catheter ablation. But ultimately it will be the quality of the ablation lesions delivered to the VT substrate that will determine the clinical outcomes. This is important because radiofrequency, the principal source of energy used in VT ablation has been presumed to be a suboptimal energy modality for catheter ablation of scar tissue. A recent study found that in experienced hands using the standard 3.5-mm tip irrigated ablation catheter, elimination of late potentials occurred during only one-third of the radiofrequency applications and electrogram reduction with impedance drop >10 Ω in just half of the radiofrequency lesions during VT ablation. 2 Yet, experimental data suggest that presence of scar by itself does not significantly impact lesion size or intramural temperatures when stable ablation catheter-tissue contact is maintained during radiofrequency energy delivery through a needle electrode. 3 As such, there seems to be a paradox-scar by itself does not significantly affect radiofrequency lesion size or intramural temperature during ablation, however, the efficacy of ablating scar tissue seems poorer than anticipated! Because tissue contact by way of a needle electrode seems most optimal, one may simply ask whether lack of a stable catheter-tissue contact could provide a plausible explanation for our disappointing clinical outcomes.
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Although no concrete data are presently available to support a direct relationship between contact force (CF) and successful elimination of abnormal ventricular electrograms or VT recurrence after catheter ablation, it is conceivable that poor or unstable contact between the ablation catheter tip and myocardial tissue could gravely impact VT ablation outcomes. Sacher et al 4 have previously shown that lesion formation during radiofrequency ablation could significantly improve in nearly one quarter of the applications with the aid of CF feedback. CF also seems to be the principal determinant of epicardial radiofrequency lesion size, steam pops, acute coronary artery, and phrenic nerve injury. 5 In fact, ablation using sufficiently high CF has even been shown to create small myocardial radiofrequency lesions at sites covered by thick epicardial fat (>3.5 mm) 5 -that is, epicardial sites at which the heavy fat layer would otherwise seriously impede radiofrequency lesion formation.
Although the optimal CF for ventricular mapping and ablation has yet to be determined, in this issue of Circulation: Arrhythmia and Electrophysiology, Jesel et al 6 provide important insights into regional variations in CF and catheter orientation relating to epicardial and endocardial mapping. Briefly, the authors evaluated CF variability using a cooled-tip mapping/ablation catheter (Thermocool SmartTouch, Biosense Webster, Inc, Diamond Bar, CA) during endocardial and epicardial mapping in a cohort of patients with and without structural heart disease undergoing catheter ablation of VT, by 2 experienced operators blinded to the collected CF data. Several findings from this article are noteworthy. First, bipolar signal amplitude in healthy endocardial and epicardial tissue was found to increase with CF ≤10 g, but not beyond. As such, based on a general linear mixed model analysis, the best CF cutoff value for obtaining a signal amplitude >1.5 mV was determined to be 7 g in the left ventricular (LV) endocardium (sensitivity: 80%, specificity: 75%), 9 g in the right ventricular (RV) endocardium (sensitivity: 65%, specificity: 83%), and 4 g in the epicardium (sensitivity: 83%, specificity: 64%). These findings are also consistent with other published reports. Similarly, Mizuno et al 7 recently showed that the optimal CF cutoff value to predict adequate tissue contact during LV endocardial and epicardial mappings was 9 g.
Second, the authors detected no significant differences between transseptal and retrograde LV mapping strategies, with the exception of a higher incidence of greater CF (defined by >20 g) observed with the transseptal approach. CF was shown to be lower on the LV basal septal and anterobasal regions with either transseptal or retrograde mapping and also low on the RV septal and apical regions, whereas CF was greatly improved with transseptal mapping of the LV apical septal and apical inferior regions and mapping of the RV free wall. This is notable and calls for greater attention during mapping and ablation of the RV, as free wall perforations can occur with vigorous catheter manipulations in this area often posing catastrophic consequences. Meanwhile, epicardial CF was greatly reduced in the apical and lateral LV segments even in presence of optimal catheter orientation. Nonetheless, it should be emphasized that some of these findings may have
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December 2014 been influenced by operator practices. For instance, the degree of CF may have been intentionally reduced when manipulating the catheter within the RV apex to avoid myocardial perforation. Similarly, the differences in CF noted during epicardial mapping may merely reflect the operators' preference for an anterior epicardial puncture. The authors also observed that the degree of CF applied during endocardial ventricular mapping (15 g inside the LV and 13 g inside the RV) was significantly greater than that applied during epicardial mapping (8 g). Furthermore, the catheter orientation was directed toward the myocardium >90% of the time when mapping the LV and the RV endocardially but only <50% during epicardial mapping. This finding was particularly apparent during epicardial mapping of the LV apical and basal regions where optimal catheter orientation was achieved ≤30% of the time. As such, suboptimal catheter orientation during epicardial mapping was frequently associated with higher CF measurements (16 g when pointing away from the epicardial surface versus 8 g when directed toward the heart; P<0.0001), suggesting that increased CF during epicardial mapping did not necessarily imply adequate myocardial contact. On the contrary, application of higher CF epicardially may in fact redirect the catheter away from the myocardium toward extracardiac structures (eg, parietal pericardium, lungs). These observations are also consistent with results from the authors' prior animal study, 4 which demonstrated that total CF was greater endocardially as a result of increased axial force. Conversely, assessment of lateral CF seems more relevant when ablation is performed epicardially. As proposed by the authors, it is plausible that such differences may also account for certain lesion characteristics considered more typical of epicardial ablation (ie, shallower and wider radiofrequency applications). These findings are of pivotal importance indicating that while CF is relevant to endocardial ablation, catheter orientation may in fact be more pertinent to the safety and efficacy of epicardial ablation.
Yet, there may be another possible explanation for the authors' findings of higher epicardial CF when the ablation catheter is directed away from the myocardium. To understand this, it is important to first review the manner in which CF is quantified using the Thermocool SmartTouch catheter. Using this technology, CF is determined electromechanically based on the amount of mechanical deformation experienced by the catheter tip. This is in effect different from the mechanism utilized by the TactiCath ablation catheter (St. Jude Medical, Inc, St. Paul, MN), which relies on white light interferometry (diffraction of light) to gauge real-time catheter tip deflection. As such, pointing the SmartTouch catheter vector away intrapericardially from the heart may result in a higher degree of mechanical tip deformation against the pericardium, which in turn could register a greater (and likely overestimated) CF value-providing an alternative explanation for the authors' findings. A situation contrary to this may be encountered during endocardial catheter mapping/ablation along the left pulmonary vein-atrial appendage ridge. Although a significant amount of force can be exerted in this area during counterclockwise rotation of the sheath (perhaps even to the point of causing significant deformation within the ridge as visualized by intracardiac echocardiography), this may not necessarily translate into higher CF measurements by the catheter as the catheter tip itself sits parallel to the tissue and may not be sufficiently deformed within this region. Albeit adequate tissue contact, the reduced catheter tip deformation in this area may yield an underestimated CF value. This is in fact consistent with results from other studies which have reported epicardial CF measurements as high as 70 g using the TactiCath ablation catheter 5 but values much lower (often a fraction of that) with the use of the SmartTouch catheter.
In summary, great strides have been made in our knowledge and understanding of catheter mapping and ablation of VT within the past 3 decades. The addition of force sensing technologies to the pre-existing mapping/ablation catheters clearly represents another innovative milestone in advancing this technology, while holding great promise for improving our ablation outcomes. Further research is needed to enhance our understanding and interpretation of the available data in the hopes of continuing to improve the outcomes from VT ablation. As such, the article by Jesel et al 6 represents an excellent starting point.
